Bilateral megaureters in the Adriamycin rat model

Area of Science:

• Developmental biology
• Toxicology
• Urology

Background:

• Congenital obstructive uropathy presents a significant health challenge in neonates, yet its underlying pathophysiology remains unclear.
• Existing experimental models for prenatal urinary tract obstruction are limited, necessitating new approaches.
• Prenatal Adriamycin exposure in rats is known to induce various malformations, including urinary tract anomalies.

Purpose of the Study:

• To investigate the incidence of urinary tract anomalies resulting from Adriamycin administration during specific gestational windows in rat embryos.
• To identify the critical period of Adriamycin exposure that maximizes the occurrence of these anomalies.

Main Methods:

• Pregnant rats received Adriamycin (1.75 mg/kg) intraperitoneally on gestational days 6-10.
• Control groups received saline.
• Embryos were recovered on day 21, examined for external and internal urinary tract malformations, and processed for histological analysis.

Main Results:

• Adriamycin administration on gestational days 7-9 resulted in a 91.6% incidence of urinary tract anomalies, compared to 16% in controls.
• The most frequent anomaly was bilateral megaureters with a hypoplastic bladder (81%).
• Other observed anomalies included ureterohydronephrosis, duplex kidney, and renal agenesis.

Conclusions:

• Gestational days 7-9 represent a critical window for Adriamycin-induced bilateral megaureters with a small bladder in the rat model.
• This Adriamycin-induced rat model offers a valuable tool for further investigation into the pathophysiology of congenital obstructive uropathy.